In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis

Overview of attention for article published in Journal of Nanobiotechnology, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 27 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,907 followers.

#DYK you can simulate the flow of aqueous humour in the eye with an Ismatec® multichannel pump? https://t.co/3IKQh7ftDP https://t.co/Vbgj33BLrx #ScientificExperts #FluidHandling #PeristalticPump https://t.co/FsRLYzB3qp

19 Mar 2020

Reply Repost Favourite

Open Access UCL Research: In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis - UCL Discovery https://t.co/QBXli5A6RB

07 Dec 2018

Reply Repost Favourite

J Nanobiotechnology In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis https://t.co/AXiQw1ei2Z #Research via @BioMedCentral https://t.co/tTvkP57k7T

28 Nov 2018

Reply Repost Favourite